Federal court puts kibosh on Trump plan for drug prices in TV adsA federal judge has blown a hole in an attempt by the Trump administration to force drugmakers to Share XFederal court puts kibosh on Trump plan for drug prices in TV adshttps://pharmaphorum.com/news/federal-court-puts-kibosh-on-trump-plan-for-drug-prices-in-tv-ads/
Trump promises ‘favoured nation’ drug price clausePresident Donald Trump is preparing an executive order outlining a “favoured nations clause”, where US prices will reflect Share XTrump promises ‘favoured nation’ drug price clausehttps://pharmaphorum.com/news/trump-promises-favoured-nation-drug-price-clause/
UnitedHealth buys PatientsLikeMe after Trump interventionThe US health services giant UnitedHealth Group has bought PatientsLikeMe, which had been forced to find a buyer Share XUnitedHealth buys PatientsLikeMe after Trump interventionhttps://pharmaphorum.com/news/unitedhealth-buys-patientslikeme-after-trump-intervention/
Trump budget proposal cuts NIH research, retains border wall planPresident Trump’s latest budget proposal retains a controversial $8.6 billion request for a border wall with Mexico, while Share XTrump budget proposal cuts NIH research, retains border wall planhttps://pharmaphorum.com/news/trump-budget-proposal-cuts-nih-research-retains-border-wall-plan/
Former Trump lawyer Cohen says Novartis ‘wanted him to be lobbyist’Novartis’ dodgy dealings with the Trump administration have come under fresh scrutiny, as his former personal lawyer Michael Share XFormer Trump lawyer Cohen says Novartis ‘wanted him to be lobbyist’https://pharmaphorum.com/news/novartis-wanted-former-trump-cohen-lobbyist/
FDA decisions could ‘slow to crawl’ because of government shutdownExperts have said the ongoing government shutdown may already have delayed approval and launch of new drugs, as Share XFDA decisions could ‘slow to crawl’ because of government shutdownhttps://pharmaphorum.com/news/fda-decisions-could-slow-to-crawl-because-of-government-shutdown/
FDA delays review of peanut allergy drug amid Trump shutdownOne of the first pharma victims of the current partial shutdown of the US government has emerged after Share XFDA delays review of peanut allergy drug amid Trump shutdownhttps://pharmaphorum.com/news/fda-delays-review-of-peanut-allergy-drug-amid-trump-shutdown/
Pfizer to hike prices of 41 drugs despite Trump criticismPfizer plans to raise the prices of 41 prescription drugs in January, despite falling foul of President Trump, Share XPfizer to hike prices of 41 drugs despite Trump criticismhttps://pharmaphorum.com/news/pfizer-to-hike-prices-of-41-drugs-despite-trump-criticism/
Democrats vow to tackle drug prices after midterm victoryDrug companies could come under increased pressure to lower prices in the US, after the opposition Democrat party Share XDemocrats vow to tackle drug prices after midterm victoryhttps://pharmaphorum.com/news/democrats-vow-to-tackle-drug-prices-after-midterm-victory/
